Mindray North America, a prominent developer of healthcare technologies, has introduced a significant advancement in cybersecurity.

Their flagship patient monitoring devices, the BeneVision N12, N15, and N17 monitors, have achieved certification under the UL Solutions Cybersecurity Assurance Program (CAP) to UL 2900-2-1.

This marks a notable achievement as the first medical devices from China to secure this certification. UL Solutions, known for its independent testing and certification services, facilitated this milestone.

Mindray's pursuit of this certification was motivated by the urgent cybersecurity challenges in healthcare. They aimed for a rigorous, process-driven approach to cybersecurity assessment throughout the product lifecycle.

According to Frank Menzel, Program Director of System Solutions at Mindray North America, the UL Solutions Cybersecurity Assurance Program perfectly aligns with this vision.

The UL 2900-2-1 certification evaluates both product and system security for network-connected devices, as well as the development and maintenance processes employed by vendors. It emphasizes robust security measures.

The certification process signifies Mindray's dedication to delivering top-notch solutions that meet or exceed industry standards for cybersecurity.

The alignment with other cybersecurity frameworks such as the NIST cybersecurity framework and the FDA consensus standard UL 2900-2-1 for medical device cybersecurity.

For healthcare organizations evaluating product compatibility with their cybersecurity programs, the UL Solutions certification offers assurance that Mindray's patient monitors seamlessly integrate into existing systems.

The BeneVision N12, N15, and N17 monitors cater to various care settings, including OR, ICU, NICU, and ER/Trauma, empowering healthcare providers with a modular design, extensive parameter options, and specialized Clinical Assistance Applications (CAAs) to enhance clinical excellence and operational efficiency.





Source: prnewswire.com

Report Abuse